| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.
|
Lancet
|
2009
|
7.24
|
|
2
|
Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial.
|
Lancet
|
2010
|
4.89
|
|
3
|
Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human.
|
Nature
|
2012
|
3.41
|
|
4
|
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries.
|
Circulation
|
2007
|
3.01
|
|
5
|
Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
|
Hepatology
|
2013
|
2.84
|
|
6
|
Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial.
|
Eur Heart J
|
2007
|
2.56
|
|
7
|
The prevalence, anatomical correlates and treatment of sleep-disordered breathing in obese children and adolescents.
|
Sleep Med Rev
|
2008
|
2.33
|
|
8
|
Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring.
|
Diabetes Care
|
2006
|
2.18
|
|
9
|
Body surface area in normal-weight, overweight, and obese adults. A comparison study.
|
Metabolism
|
2006
|
2.14
|
|
10
|
Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia.
|
Arterioscler Thromb Vasc Biol
|
2010
|
2.03
|
|
11
|
Variants in the FTO gene are associated with common obesity in the Belgian population.
|
Mol Genet Metab
|
2007
|
1.82
|
|
12
|
Sleep-disordered breathing in overweight and obese children and adolescents: prevalence, characteristics and the role of fat distribution.
|
Arch Dis Child
|
2006
|
1.67
|
|
13
|
Prevalence of loss-of-function FTO mutations in lean and obese individuals.
|
Diabetes
|
2009
|
1.54
|
|
14
|
C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients.
|
J Hepatol
|
2011
|
1.54
|
|
15
|
The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis.
|
PLoS One
|
2013
|
1.22
|
|
16
|
Obesity and persistent organic pollutants: possible obesogenic effect of organochlorine pesticides and polychlorinated biphenyls.
|
Obesity (Silver Spring)
|
2010
|
1.19
|
|
17
|
Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.
|
Eur J Endocrinol
|
2009
|
1.19
|
|
18
|
Effect of long-term whole body vibration training on visceral adipose tissue: a preliminary report.
|
Obes Facts
|
2010
|
1.14
|
|
19
|
Flow mediated dilatation and cardiac function in type 1 diabetes mellitus.
|
Am J Cardiol
|
2005
|
1.13
|
|
20
|
Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.
|
Diabetes Care
|
2011
|
1.12
|
|
21
|
Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity.
|
Diabetes
|
2011
|
1.12
|
|
22
|
Safety and efficacy of once-weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes over 84 weeks.
|
Diabetes Care
|
2012
|
1.04
|
|
23
|
Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status.
|
Diabetes Metab Res Rev
|
2006
|
0.99
|
|
24
|
Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals.
|
PLoS One
|
2013
|
0.97
|
|
25
|
Glucose control and use of continuous glucose monitoring in the intensive care unit: a critical review.
|
Curr Diabetes Rev
|
2008
|
0.97
|
|
26
|
Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.
|
Metabolism
|
2009
|
0.97
|
|
27
|
Loss-of-function mutations in SIM1 contribute to obesity and Prader-Willi-like features.
|
J Clin Invest
|
2013
|
0.96
|
|
28
|
Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids.
|
Diabetologia
|
2013
|
0.95
|
|
29
|
Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients.
|
Clin Gastroenterol Hepatol
|
2012
|
0.94
|
|
30
|
Sleep-disordered breathing and uric acid in overweight and obese children and adolescents.
|
Chest
|
2007
|
0.94
|
|
31
|
Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel.
|
Curr Med Res Opin
|
2005
|
0.91
|
|
32
|
The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men.
|
Endocrine
|
2007
|
0.91
|
|
33
|
Efficacy and safety of the weight-loss drug rimonabant.
|
Lancet
|
2008
|
0.91
|
|
34
|
Echocardiographic evidence for valvular toxicity of benfluorex: a double-blind randomised trial in patients with type 2 diabetes mellitus.
|
PLoS One
|
2012
|
0.90
|
|
35
|
The effect of weight loss on sleep-disordered breathing in obese teenagers.
|
Obesity (Silver Spring)
|
2009
|
0.90
|
|
36
|
The effect of whole body vibration short-term exercises on respiratory gas exchange in overweight and obese women.
|
Phys Sportsmed
|
2009
|
0.89
|
|
37
|
A review of current evidence with continuous glucose monitoring in patients with diabetes.
|
J Diabetes Sci Technol
|
2008
|
0.89
|
|
38
|
Minimally-invasive and non-invasive continuous glucose monitoring systems: indications, advantages, limitations and clinical aspects.
|
Curr Diabetes Rev
|
2008
|
0.88
|
|
39
|
Association of the BDNF Val66Met variation with obesity in women.
|
Mol Genet Metab
|
2008
|
0.88
|
|
40
|
Dynamics of organohalogenated contaminants in human serum from obese individuals during one year of weight loss treatment.
|
Environ Sci Technol
|
2013
|
0.87
|
|
41
|
Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results.
|
J Hypertens
|
2008
|
0.87
|
|
42
|
Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum.
|
Diabetes Care
|
2015
|
0.86
|
|
43
|
Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
|
Cytokine
|
2012
|
0.86
|
|
44
|
Long term magnesium supplementation influences favourably the natural evolution of neuropathy in Mg-depleted type 1 diabetic patients (T1dm).
|
Magnes Res
|
2004
|
0.86
|
|
45
|
Sleep-disordered breathing and C-reactive protein in obese children and adolescents.
|
Sleep Breath
|
2013
|
0.85
|
|
46
|
Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial.
|
Pituitary
|
2015
|
0.85
|
|
47
|
Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis.
|
Eur J Gastroenterol Hepatol
|
2010
|
0.83
|
|
48
|
Plasma adiponectin level is inversely correlated with albuminuria in overweight and obese nondiabetic individuals.
|
Metabolism
|
2013
|
0.83
|
|
49
|
Overweight in adolescents: differences per type of education. Does one size fit all?
|
J Nutr Educ Behav
|
2008
|
0.83
|
|
50
|
Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device.
|
Diabetes Metab Res Rev
|
2004
|
0.83
|
|
51
|
Impact of waist circumference difference on health-care cost among overweight and obese subjects: the PROCEED cohort.
|
Value Health
|
2010
|
0.82
|
|
52
|
Early response to sibutramine in patients not meeting current label criteria: preliminary analysis of SCOUT lead-in period.
|
Obesity (Silver Spring)
|
2009
|
0.80
|
|
53
|
Possible role for ENPP1 polymorphism in obesity but not for INSIG2 and PLIN variants.
|
Endocrine
|
2009
|
0.80
|
|
54
|
Relation between disease phenotype and HLA-DQ genotype in diabetic patients diagnosed in early adulthood.
|
J Clin Endocrinol Metab
|
2002
|
0.80
|
|
55
|
Coenzyme Q as an antiadipogenic factor.
|
Antioxid Redox Signal
|
2010
|
0.78
|
|
56
|
Belgian expert opinion: how to reduce the residual risk in atherogenic dyslipidaemic patients: place of fibrates.
|
Acta Cardiol
|
2008
|
0.78
|
|
57
|
Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin.
|
Atherosclerosis
|
2004
|
0.78
|
|
58
|
Diabetic keto-acidosis as a presentation of cystic fibrosis-related diabetes: a case report.
|
J Diabetes Complications
|
2010
|
0.76
|
|
59
|
Prolonged flare-up of testosterone after administration of a gonadotrophin agonist to a sex offender: an under-recognised risk?
|
Crim Behav Ment Health
|
2015
|
0.76
|
|
60
|
LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial.
|
J Hypertens
|
2016
|
0.76
|
|
61
|
Metabolic syndrome in youth: a cross-sectional school-based survey.
|
Acta Paediatr
|
2007
|
0.76
|
|
62
|
Obesity in Europe - does anybody care?
|
Expert Opin Pharmacother
|
2013
|
0.76
|
|
63
|
Phthalate metabolites in obese individuals undergoing weight loss: Urinary levels and estimation of the phthalates daily intake.
|
Environ Int
|
2013
|
0.76
|
|
64
|
Sleep duration and insulin resistance in obese children: when variables are sleeping too close together.
|
J Pediatr
|
2007
|
0.75
|
|
65
|
Adenotonsillectomy as first-line treatment for sleep-disordered breathing in obese children.
|
Am J Respir Crit Care Med
|
2008
|
0.75
|
|
66
|
Lixisenatide treatment for older patients with type 2 diabetes mellitus uncontrolled on oral antidiabetics: meta-analysis of five randomized controlled trials.
|
Adv Ther
|
2014
|
0.75
|
|
67
|
Pharmacologic treatment of obesity.
|
J Obes
|
2012
|
0.75
|
|
68
|
Fainting and hemolysis during blood sampling in youngsters: prevalence study.
|
Int J Nurs Stud
|
2007
|
0.75
|
|
69
|
Evolution of serum alpha-tocopherol in the postprandial and postabsorptive phases in type 1 diabetes mellitus.
|
Ann N Y Acad Sci
|
2004
|
0.75
|
|
70
|
Relation between weight loss and causes of death in patients with cardiovascular disease: finding from the SCOUT trial.
|
J Cardiovasc Med (Hagerstown)
|
2017
|
0.75
|
|
71
|
The Effect of Lifestyle Interventions on Excess Ectopic Fat Deposition Measured by Noninvasive Techniques in Overweight and Obese Adults: A Systematic Review and Meta-Analysis.
|
J Phys Act Health
|
2015
|
0.75
|